Russell Frank Company’s Pacific Biosciences PACB Stock Holding History

Russell Frank Company’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$663K	Sell	78,035 -10,130	-11%	-$99.6K	﹤0.01%	2347
2015 Q4	$1.16M	Buy	+88,165	New	+$791K	﹤0.01%	2141
2014 Q2	–	Sell	-89,743	Closed	-$395K	–	2826
2014 Q1	$395K	Sell	89,743 -38,700	-30%	-$245K	﹤0.01%	2445
2013 Q4	$922K	Sell	128,443 -210,669	-62%	-$967K	﹤0.01%	2101
2013 Q3	$1.88M	Buy	339,112 +306,868	+952%	+$1.07M	﹤0.01%	1899
2013 Q2	$81K	Buy	+32,244	New	+$80.3K	﹤0.01%	2794

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Russell Frank Company's PACB Position: Q1 2016 in Review

Russell Frank Company reduced its Pacific Biosciences (PACB) stake by 11% in Q1 2016, selling an estimated $99.6K and leaving 78,035 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

Russell Frank Company first reported a position in PACB in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.88M in Q3 2013. 129 funds tracked by Wall St. Rank hold PACB as of Q1 2016.

Russell Frank Company held 78,035 shares of Pacific Biosciences worth $663K as of Q1 2016.
Russell Frank Company sold 10,130 Pacific Biosciences shares in Q1 2016, an estimated $99.6K.
Pacific Biosciences made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2347 holding.
Russell Frank Company first reported a position in Pacific Biosciences in Q2 2013 and has held it in 6 quarters since.
Russell Frank Company's Pacific Biosciences position peaked at $1.88M in Q3 2013.
129 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.